Eng F J, Novikova E G, Kuroki K, Ganem D, Fricker L D
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
J Biol Chem. 1998 Apr 3;273(14):8382-8. doi: 10.1074/jbc.273.14.8382.
Duck gp180 was previously identified by its ability to bind to the preS envelope protein of duck hepatitis B virus particles (Kuroki, K. , Cheung, R., Marion, P. L., and Ganem, D. (1994) J. Virol. 68, 2091-2096). Cloning and sequencing of gp180 cDNA revealed that it is a polyprotein with three carboxypeptidase-like domains (Kuroki, K., Eng, F., Ishikawa, T., Turck, C., Harada, F., and Ganem, D. (1995) J. Biol. Chem. 270, 15022-15028). To evaluate enzymatic properties of this protein, a soluble 170-kDa form of the protein (gp170) lacking the C-terminal transmembrane domain and cytoplasmic tail was expressed in a baculovirus system. The purified 170-kDa protein cleaved 5-dimethylaminonaphthalene-1-sulfonyl (dansyl)-Phe-Ala-Arg with a pH optimum of 5.5-6.5. With this substrate at pH 5.5, the 170-kDa protein displayed a Km of 12 microM and a Kcat of 57 s-1. Dansyl-Pro-Ala-Arg and dansyl-Phe-Phe-Arg were cleaved with Km values of 17 and 21 microM, and Kcat values of 57 and 17 s-1, respectively. Constructs containing only the first or second carboxypeptidase domains also showed enzymatic activity. The effects of inhibitors and ions on enzyme activity of gp170 were generally similar to the effects of these compounds on purified bovine carboxypeptidase D. To evaluate the regions within gp180 necessary for binding preS, a series of deletion mutants were expressed in the 293T human kidney cell line. Deletions of the first and second domains, leaving the third domain intact, eliminated carboxypeptidase activity but retained preS binding. Deletion of the third domain eliminated preS binding but not carboxypeptidase activity. These results indicate that the third domain is responsible for preS binding, and this binding does not require carboxypeptidase activity.
鸭gp180先前是通过其与鸭乙型肝炎病毒颗粒的前S包膜蛋白的结合能力而被鉴定出来的(黑木 克、张 润、马里昂 彼得·L.、加内姆 大卫(1994年)《病毒学杂志》68卷,2091 - 2096页)。gp180 cDNA的克隆和测序显示它是一种具有三个羧肽酶样结构域的多聚蛋白(黑木 克、恩格 弗、石川 哲、图尔克 克、原田 芳、加内姆 大卫(1995年)《生物化学杂志》270卷,15022 - 15028页)。为了评估该蛋白的酶学性质,一种缺少C末端跨膜结构域和胞质尾的170 kDa可溶性形式的蛋白(gp170)在杆状病毒系统中表达。纯化的170 kDa蛋白可切割5 - 二甲氨基萘 - 1 - 磺酰基(丹磺酰基)- 苯丙氨酸 - 丙氨酸 - 精氨酸,最适pH为5.5 - 6.5。在pH 5.5时,以该底物作用,170 kDa蛋白的Km值为12 μM,Kcat值为57 s⁻¹。丹磺酰基 - 脯氨酸 - 丙氨酸 - 精氨酸和丹磺酰基 - 苯丙氨酸 - 苯丙氨酸 - 精氨酸分别被切割,Km值分别为17和21 μM,Kcat值分别为57和17 s⁻¹。仅包含第一个或第二个羧肽酶结构域的构建体也显示出酶活性。抑制剂和离子对gp170酶活性的影响通常与这些化合物对纯化的牛羧肽酶D的影响相似。为了评估gp180中与前S结合所需的区域,一系列缺失突变体在293T人肾细胞系中表达。缺失第一和第二个结构域而保留第三个结构域,消除了羧肽酶活性但保留了前S结合能力。缺失第三个结构域消除了前S结合能力但没有消除羧肽酶活性。这些结果表明第三个结构域负责前S结合,并且这种结合不需要羧肽酶活性。